Oral Chemotherapy and Quality of Care
PARCOURS
Community and Hospital Experiences for Patients Treated by Oral Chemotherapy at the University Hospital of Caen: Analysis of the Process and Its Dysfunctions
1 other identifier
observational
60
1 country
1
Brief Summary
PARCOURS is a non-interventional research study evaluating dysfunctions in the continuous city-hospital journey of a patients cohort treated by oral chemotherapy (60 patients followed for 3 months). References used are the National Cancer Institute recommendations for the oral chemotherapy treated outpatients. Parameters found are : information exchanged, ambulatory and hospital monitoring in case of adverse event and adherence to treatment. The study includes also a medico-economic evaluation (hospitalization and transport spending in case of dysfunction in the patient's journey). Deviations will be analyzed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 29, 2018
CompletedFirst Submitted
Initial submission to the registry
May 25, 2018
CompletedFirst Posted
Study publicly available on registry
June 19, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 29, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 29, 2018
CompletedJune 19, 2018
May 1, 2018
3 months
May 25, 2018
June 7, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Number of dysfunctions
Number of dysfunctions objectified during the 3-month follow-up period, by sub-processes of the course
3 months
Secondary Outcomes (8)
Drug adherence
3 months
Drug adherence
3 months
Adverse events
3 months
Expenses related to the use of unplanned hospital care
3 months
Satisfaction of the patient
At month 3
- +3 more secondary outcomes
Interventions
Evaluation of dysfunctions in the continuous city-hospital journey of a patients cohort treated by oral chemotherapy
Eligibility Criteria
Adult outpatients treated by oral chemotherapy for a cancer disease
You may qualify if:
- Patient over 18 years old
- Suffering from cancer (hematological malignancies, digestive tumors, thoracic tumors or cutaneous tumors)
- With an oral anticancer chemotherapy initial prescription written by an oncologist or hematologist from the University Hospital of Caen, whatever the place of the drug dispensing (Community pharmacy or hospital pharmacy )
You may not qualify if:
- \- Patient treated by oral anticancer chemotherapy for another pathology
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Caenlead
- MSD Francecollaborator
Study Sites (1)
Caen University Hopsital
Caen, France
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 25, 2018
First Posted
June 19, 2018
Study Start
March 29, 2018
Primary Completion
June 29, 2018
Study Completion
September 29, 2018
Last Updated
June 19, 2018
Record last verified: 2018-05